Konditionerende Smertestimuli - Sammenligning af Forskellige Test og Konditioneringsmodaliteter
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 25
- 试验地点
- 1
- 主要终点
- CPM efficacy
研究概览
简要总结
An extensive amount of studies indicate that conditioned pain modulation (CPM) test paradigms can be of use to evaluate the efficacy of the endogenous pain inhibition pathway in healthy controls and pain patients. A number of studies indicate that the autonomic nervous system (ANS) responds to painful stimulation by parasympathetic activity withdrawal and up-regulation of sympathetic activity (flight-or-fight mode), but it remains unknown whether these responses predict individual pain susceptibility or CPM efficacy and whether different pain modalities evoke different physiological stress responses, i.e. do individuals with low pain tolerance exhibit more vigorous ANS responses when subjected to controlled acute pain stimuli, and do high ANS responsiveness to pain coincide with altered psychophysical pain levels/CPM efficacy.
This study aims to investigate the effect of ANS responsiveness on CPM paradigms and to investigate if an exogenous, pharmaceutically induced decrease in the sympathetic drive of the ANS will yield decreased CPM efficacy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Basic Science
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 45 Years(Adult)
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Healthy subjects
排除标准
- •Drug addiction defined as the use of cannabis, opioids or other drugs
- •Previous history of neurologic, musculoskeletal, mental illnesses or a chronic pain condition
- •Lack of ability to cooperate
- •Current use of medications that may affect the trial, e.g., analgesics, anti-inflammatory drugs
- •Consumption of alcohol, caffeine, nicotine or painkillers the morning and until termination of the study on the study day
- •Recent history of acute pain affecting the lower limb
- •Participation in other pain trials throughout the study period
- •Known diagnosis of cardio vascular diseases (low blood pressure, heart conditions)
- •Decreased function of liver and kidneys
研究组 & 干预措施
Propranolol
Propranolol is a beta-blocker
干预措施: propranolol (Drug)
Placebo
Placebo
干预措施: Placebo (Drug)
结局指标
主要结局
CPM efficacy
时间窗: 1-2 hours after propranolol/placebo and after 10 minutes break.
A test stimuli will be applied and compared with a test stimuli simultaneous a condition stimuli.
次要结局
- Temporal summation of pain(1-2 hours after propranolol/placebo and after 10 minutes break.)
- Heart-rate variability(1-2 hours after propranolol/placebo and after 10 minutes break.)
- Offset analgesia(1-2 hours after propranolol/placebo and after 10 minutes break.)
研究者
Kristian Kjær Petersen
M.Sc, Ph.d.
Aalborg University
